XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash provided (required) by operating activities of continuing operations:      
Net income (loss) $ 734.0 $ 550.6 $ 480.2
Discontinued operations, net of income taxes 68.2 28.3 63.3
Income (loss) from continuing operations 802.2 578.9 543.5
Adjustments from income (loss) from continuing operations to cash provided (required) by operating activities of continuing operations:      
Depreciation and amortization 170.9 162.7 150.1
Restructuring and other charges (income) 108.0 132.2 171.0
Deferred income taxes 9.7 33.6 46.1
Pension and other postretirement benefits 24.9 25.8 12.6
Share-based compensation 17.8 18.9 25.6
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:      
Trade receivables, net (241.1) (71.8) (123.5)
Guarantees of vendor financing 65.6 64.8 8.6
Advance payments from customers 283.6 (145.5) 34.1
Accrued customer rebates 108.7 17.2 (85.8)
Inventories (331.1) (59.7) 6.4
Accounts payable, trade and other 144.4 61.8 103.0
Income taxes (90.3) 36.2 (25.0)
Pension and other postretirement benefit contributions (5.3) (4.6) (13.4)
Environmental spending, continuing, net of recoveries (63.6) (1.9) (18.3)
Restructuring and other spending [1] (34.7) (17.9) (18.6)
Transaction and integration costs (9.5) (63.9) (77.1)
Change in other operating assets and liabilities, net [2] (61.6) (30.0) (183.7)
Cash provided (required) by operating activities of continuing operations 898.6 736.8 555.6
Cash provided (required) by operating activities of discontinued operations:      
Environmental spending, discontinued, net of recoveries (57.5) (58.9) (51.7)
Operating activities of discontinued operations, net of divestiture costs 0.0 (0.2) 9.0
Other discontinued spending (21.0) (29.9) (24.4)
Cash provided (required) by operating activities of discontinued operations (78.5) (89.0) (67.1)
Cash provided (required) by investing activities of continuing operations:      
Capital expenditures (100.1) (67.2) (93.9)
Investment in Enterprise Resource Planning system (12.7) (47.2) (48.0)
Acquisitions, including cost and equity method, net [3] (5.2) (65.6) 0.0
Other investing activities [4] (13.7) (20.4) (54.0)
Cash provided (required) by investing activities of continuing operations (131.7) (200.4) (195.9)
Cash provided (required) by investing activities of discontinued operations:      
Proceeds from disposal of property, plant and equipment 19.7 31.1 26.2
Other discontinued investing activities 0.0 0.0 (17.0)
Cash provided (required) by investing activities of discontinued operations 19.7 31.1 9.2
Cash provided (required) by financing activities of continuing operations:      
Increase (decrease) in short-term debt 104.9 97.0 (11.9)
Proceeds from borrowing of long-term debt 1,000.0 27.1 1,500.0
Financing fees and interest rate swap settlements (2.4) (3.5) (97.4)
Repayments of long-term debt (1,203.1) (100.0) (901.9)
Acquisitions of noncontrolling interests 0.0 (7.4) 0.0
Distributions to noncontrolling interests 0.0 (1.3) 0.0
Dividends paid [5] (247.2) (228.5) (210.3)
Issuances of common stock, net 7.9 24.7 50.7
Repurchases of common stock under publicly announced program (400.0) (50.0) (400.0)
Other repurchases of common stock (8.0) (8.4) (16.2)
Cash provided (required) by financing activities of continuing operations (747.9) (250.3) (87.0)
Cash provided (required) by financing activities of discontinued operations:      
Payment of Livent external debt 0.0 0.0 (27.0)
Cash transfer to Livent due to spin 0.0 0.0 (10.2)
Cash provided (required) by financing activities of discontinued operations 0.0 0.0 (37.2)
Effect of exchange rate changes on cash and cash equivalents (12.3) 1.6 (0.2)
Increase (decrease) in cash and cash equivalents (52.1) 229.8 177.4
Cash and cash equivalents of continuing operations, beginning of period 568.9 339.1 134.4
Cash and cash equivalents of discontinued operations, beginning of period [6] 0.0 0.0 27.3
Cash and cash equivalents, beginning of period   568.9 339.1
Less: cash and cash equivalent of discontinued operations, end of period [6]   0.0 0.0
Cash and cash equivalents, end of period $ 516.8 $ 568.9 $ 339.1
[1] The restructuring and other spending amount includes spending of $6.0 million related to the Furadan® asset retirement obligations and also includes $4.4 million of payments for certain historical India indirect tax matters. For additional detail on restructuring and other charges activities, see Note 9 to our consolidated financial statements included within this Form 10-K.
[2] Changes in all periods represent timing of payments associated with all other operating assets and liabilities.
[3] The acquisitions, net amount in 2020 represents payments made on October 2, 2020 to acquire the remaining rights for Fluindapyr from Isagro S.p.A ("Isagro") in an asset acquisition. For additional detail on this transaction, see Note 9 to our consolidated financial statements included within this Form 10-K.
[4] Cash spending associated with contract manufacturers was $18.8 million, $17.4 million and $51.7 million for the years ended December 31, 2021, 2020 and 2019, respectively.
[5] See Note 17 to the consolidated financial statements included within this Form 10-K regarding our quarterly cash dividend.
[6] Reflected within "Current assets of discontinued operations" on the consolidated balance sheets.